middle.news
How EMVision’s $3.8M Rebate and Overseas Approval Could Accelerate Stroke Tech
8:32am on Monday 16th of March, 2026 AEDT
•
Healthcare
Read Story
How EMVision’s $3.8M Rebate and Overseas Approval Could Accelerate Stroke Tech
8:32am on Monday 16th of March, 2026 AEDT
Key Points
Received $3.8 million R&D tax refund for FY2025
AusIndustry approved Advance Overseas Finding for overseas R&D costs
Eligible for 43.5% R&D tax rebate on overseas expenditures through 2027
Funding boost supports emu™ pivotal trial and market access activities
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Emvision Medical Devices (ASX:EMV)
OPEN ARTICLE